7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 
      
    		                           
      cash flows from operating activities:
    		                           
      net income
    		-2,909,000 3,643,000 -1,874,000 -2,697,000 -1,790,000 -1,045,000 4,033,000 3,010,000 387,000 -3,311,000 -949,000 -250,000 79,000 -220,000 566,000 866,000 13,000 1,327,000 446,000 387,000 -362,000 302,000 -1,441,000 -369,000 -1,217,000 -2,503,000 -1,610,000 
      adjustments to reconcile net income to net cash from (used in ) operating activities:
    		                           
      depreciation of property and equipment
    		1,573,000 1,617,000 1,682,000 1,648,000 1,771,000 1,657,000 1,594,000 1,662,000 1,487,000 1,497,000 1,488,000 1,417,000 1,393,000 1,424,000 1,311,000 1,321,000 1,343,000           
      amortization of intangible assets
    		965,000 967,000 793,000 1,499,000 661,000 718,000 692,000 694,000 695,000 258,000 256,000 259,000 259,000 116,000 23,000 24,000 24,000           
      impairment of property and equipment
    		252,000 42,000 0 0 72,000     0 0 0 25,000 73,000        54,000 271,000   127,000  
      stock-based compensation
    		2,927,000 2,710,000 2,573,000 2,479,000 2,220,000 2,137,000 2,159,000 2,131,000 1,855,000 1,550,000 1,453,000 1,494,000 1,375,000 1,216,000 1,196,000 1,163,000 887,000 682,000 716,000 905,000 754,000 645,000 748,000 648,000 427,000 322,000 231,000 
      change in fair value of contingent consideration
    		 -4,763,000 82,000 -999,000 -6,000 -312,000 -5,405,000                     
      deferred taxes
    		41,000 289,000 84,000                         
      allowance for credit losses
    		126,000 -177,000                          
      changes in operating assets and liabilities:
    		                           
      accounts receivable and contract assets
    		-4,627,000 -6,503,000                          
      prepaid expenses and other assets
    		278,000 -950,000 154,000 -75,000 -486,000 655,000 -1,517,000 133,000 -439,000 404,000 164,000 -1,375,000 134,000 -48,000 375,000 -958,000 310,000 111,000 318,000 -816,000 195,000 125,000 -323,000 -579,000 11,000 16,000 -62,000 
      accounts payable
    		-886,000 -595,000 2,121,000 -651,000 219,000 687,000 -545,000   -63,000 370,000 -98,000 145,000 -5,000 220,000 157,000 -562,000 374,000 -103,000 -168,000 -346,000 -1,061,000 -390,000 800,000 305,000 -138,000 736,000 
      accrued expenses and other liabilities
    		-1,438,000 330,000 880,000                         
      deferred revenue
    		8,675,000 3,706,000 -1,207,000 1,536,000 -6,261,000 6,751,000 1,217,000 245,000 3,417,000 4,885,000 2,046,000 -5,218,000 430,000 3,923,000 -1,665,000 -2,280,000 -2,370,000 5,624,000 -1,776,000 -1,393,000 344,000 3,737,000 2,975,000 -572,000 706,000 30,000 1,349,000 
      net cash from operating activities
    		4,977,000 316,000 9,330,000 2,503,000 -1,198,000 2,115,000 10,289,000   4,447,000 239,000 6,632,000 -1,496,000 2,400,000 3,596,000 -513,000 5,726,000 2,541,000 3,460,000 -1,214,000 8,905,000 -3,901,000 3,351,000 1,388,000 -2,224,000 1,827,000 476,000 
      capex
    		-2,134,000 -703,000 -1,134,000 -1,679,000 -1,537,000 -1,889,000 -4,273,000   -2,208,000 -2,059,000 -2,340,000 -1,233,000 -927,000 -1,104,000 -1,391,000 -494,000 -1,151,000 -1,309,000 -1,467,000 -896,000 -1,018,000 -1,783,000 -2,658,000 -2,985,000 -1,883,000 -1,677,000 
      free cash flows
    		2,843,000 -387,000 8,196,000 824,000 -2,735,000 226,000 6,016,000   2,239,000 -1,820,000 4,292,000 -2,729,000 1,473,000 2,492,000 -1,904,000 5,232,000 1,390,000 2,151,000 -2,681,000 8,009,000 -4,919,000 1,568,000 -1,270,000 -5,209,000 -56,000 -1,201,000 
      cash flows from investing activities:
    		                           
      purchase of property and equipment
    		-2,134,000 -703,000 -1,134,000 -1,679,000 -1,537,000 -1,889,000 -4,273,000 -2,853,000 -1,900,000 -2,208,000 -2,059,000 -2,340,000 -1,233,000 -927,000 -832,000 -1,183,000 -1,117,000 -1,151,000 -1,309,000 -1,467,000 -896,000 -1,018,000 -1,783,000 -2,658,000 -2,985,000 -1,883,000 -1,677,000 
      investment in intangible and other assets
    		-6,000 3,000 -390,000 -27,000 -23,000 18,000 -7,000 -9,000 -8,000 -14,000 -13,000 -19,000 -13,000 -26,000 -12,000 -10,000 -24,000 -27,000 -20,000 -5,000 -34,000 -12,000 -10,000 -16,000 -10,000 -21,000 -31,000 
      net cash from investing activities
    		-2,140,000 -700,000 -12,519,000 -1,706,000 -1,560,000 -1,871,000 -4,280,000 -2,862,000 -6,526,000 -2,222,000 -2,072,000 -2,359,000 -1,231,000 -15,580,000 -844,000 -1,193,000 -1,141,000 -1,178,000 -1,329,000 -1,472,000 -930,000 -2,741,000 -1,793,000 -2,674,000 -2,995,000 -1,904,000 -1,708,000 
      cash flows from financing activities:
    		                           
      payment of contingent consideration liability
    		 0 0 0 -1,500,000     0 0 0 -403,000 0 0 0 -347,000           
      proceeds from line of credit
    		3,000,000 0                          
      proceeds from exercise of stock options
    		 3,000 3,000 17,000 127,000 274,000 249,000 2,000 13,000 5,000 316,000 364,000 213,000 147,000 69,000 40,000 58,000 11,000 95,000 129,000 219,000 27,000 73,000 108,000 342,000 14,000 31,000 
      repurchases of common stock
    		 0 -1,947,000 -2,392,000 -1,256,000 0 0 -1,450,000 -1,634,000 0 -918,000 -491,000 -2,192,000 0 0   -3,252,000          
      payment of line of credit
    		-3,000,000                           
      net cash from financing activities
    		   -1,892,000 -2,629,000 582,000 249,000 -959,000 -1,621,000 375,000 -602,000 335,000 -2,374,000 435,000 65,000 -1,167,000 -289,000 -3,010,000 -3,351,000 504,000 11,339,000 515,000 62,000 1,518,000 342,000 321,000 -14,630,000 
      change in cash, cash equivalents and restricted cash
    		2,837,000 -124,000 1,867,000 -1,095,000 -5,387,000                       
      effect of exchange rate on cash and cash equivalents
    		-16,000 27,000 8,000 -55,000 -17,000 49,000 -80,000 -102,000 80,000 -78,000 -18,000 19,000 -2,000 122,000 25,000 20,000 -169,000 59,000 -74,000 30,000 -8,000 -3,000 -83,000 -123,000 42,000 68,000 -3,000 
      cash, cash equivalents and restricted cash at beginning of year
    		5,703,000  0 0 10,479,000 0 0 0 15,636,000        24,550,000 0 0 0 10,278,000   0 19,597,000   
      cash, cash equivalents and restricted cash at end of period
    		8,524,000  1,875,000    6,178,000          28,677,000  -1,294,000 -2,152,000 29,584,000 -6,130,000 1,537,000 109,000 14,762,000   
      supplemental cash flow disclosures:
    		                           
      property and equipment purchases included in accounts payable
    		584,000 253,000 -304,000 -546,000 1,074,000 204,000 -903,000 372,000 731,000 109,000 -44,000 -92,000 590,000               
      adjustments to reconcile net income to net cash from operating activities:
    		                           
      business acquisition, net of cash acquired
    		 0    0 0 0 -4,618,000                   
      proceeds from exercise of warrants
    		         0 0 0 8,000     0 20,000   0 -1,000     
      proceeds from employee stock purchase plan
    		 257,000 0   308,000 0   370,000 0   296,000 0   231,000 0   488,000 0     
      cash, cash equivalents at beginning of year
    		                           
      cash, cash equivalents at end of year
    		                           
      estimated fair value of contingent consideration for business combination at closing
    		                           
      fair value of common stock issued as consideration for acquisitions
    		 0                          
      net cash from (used) in financing activities
    		                           
      supplemental disclosure of non-cash financing activities:
    		                           
      fair value of contingent consideration for acquisitions
    		                           
      benefit from accounts receivable
    		   227,000 25,000 0 0 -151,000 77,000  53,000 -84,000 44,000 33,000 -8,000             
      accounts receivable and contract asset
    		   -1,107,000 4,211,000 -10,759,000 7,754,000 -6,549,000 -4,976,000 -2,748,000 -6,074,000 9,538,000 -3,929,000 -5,023,000 981,000 -575,000 6,570,000           
      estimated fair value of contingent consideration
    		      0                     
      fair value of common stock issued as consideration for business acquisition
    		     0 0 0 14,266,000                   
      accrued expenses and other current liabilities
    		    -1,834,000 941,000 307,000 919,000 -1,220,000 1,988,000 1,432,000 949,000 -1,451,000 911,000 435,000 -280,000 -491,000 181,000 437,000 300,000 -810,000 -1,106,000 1,561,000 133,000 -834,000 1,049,000 702,000 
      cash, cash equivalents and restricted cash at end of year
    		    5,075,000    8,852,000                   
      loss on disposal of property and equipment
    		             0 1,000 0 2,000           
      payment of line of credit costs
    		             -8,000        0      
      decrease in cash, cash equivalents and restricted cash
    		      6,258,000 -5,324,000 -6,864,000                   
      net cash from (used in ) operating activities
    		        1,283,000                   
      cash paid for income taxes
    		                           
      fair value of contingent consideration
    		        12,400,000                   
      proceeds from issuance of common stock upon secondary offering
    		                 0 0 0 11,247,000       
      payments of secondary offering costs
    		                           
      increase in cash, cash equivalents and restricted cash
    		                4,296,000 -1,647,000 -1,220,000 -2,182,000 19,314,000 -6,127,000      
      business acquisition purchase price adjustment
    		          0                 
      increase in cash and cash equivalents
    		          -2,435,000 4,608,000 -5,101,000  2,817,000           244,000 -15,862,000 
      cash and cash equivalents at beginning of year
    		          0 0 16,043,000  0           0 0 
      cash and cash equivalents at end of period
    		          -2,453,000 4,627,000 10,940,000  2,842,000           312,000  
      proceeds from business acquisition purchase price adjustment
    		            15,000               
      deferred offering costs included in other assets
    		                     0 183,000     
      line of credit costs included in other assets
    		                     0      
      proceeds from issuance of common stock in public offering
    		                           
      payments of offering costs
    		                  0 -318,000 -127,000      -1,012,000 
      purchases of property and equipment included in accounts payable
    		              -272,000 -208,000 623,000           
      offering costs included in accounts payable
    		                    317,000       
      depreciation and amortization
    		                 1,341,000 1,239,000 1,164,000 1,238,000 1,151,000 991,000 958,000 817,000 847,000 866,000 
      amortization of debt issuance costs
    		                         0 48,000 
      remeasurement of convertible preferred stock warrant liability
    		                         0 0 
      loss on early extinguishment of debt
    		                         0  
      business acquisition
    		                           
      proceeds from initial public offering, net of commissions and discounts
    		                         0 0 
      proceeds from notes payable
    		                         0 0 
      repayment of notes payable
    		                         0  
      payment of debt issuance costs
    		                         0 0 
      payment on debt extinguishment costs
    		                           
      payments of initial public offering costs
    		                           
      cash paid for interest
    		                         0 514,000 
      conversion of convertible preferred stock into common stock
    		                         0 0 
      reclassification of convertible preferred stock warrant liability into additional paid-in capital
    		                         0 0 
      issuance of warrants in connection with the issuance of notes payable
    		                           
      accounts receivable
    		                  2,183,000 -1,593,000 7,892,000    -2,439,000 2,217,000 -3,069,000 
      supplemental disclosure of non-cash operating activities:
    		                           
      benefit from doubtful accounts
    		                           
      accounts receivable and unbilled revenue
    		                      -1,041,000     
      payment of debt extinguishment costs
    		                           
      payment of offering costs
    		                           
      cash, cash equivalents and restricted cash at beginning of period
    		                           
      issuance of warrants in connection with the issuance of notes payable to a financial institution
    		                          0 
      decrease in cash and cash equivalents
    		                        -4,877,000   
      debt origination fees included in accrued expenses and other current liabilities
    		                           
      proceeds from issuance of series b-1 convertible preferred stock, net of issuance costs
    		                           
      repayment of line of credit
    		                           
      proceeds from espp
    		                           
      deferred offering costs included in accounts payable and accruals
    		                          -973,000 
      cash and cash equivalents at end of year
    		                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.